Home › Funds › HARBOURVEST PARTNERS LLC › CAMP
HARBOURVEST PARTNERS LLC position in CAMP
CAMP4 THERAPEUTICS CORP · Health Care
HARBOURVEST PARTNERS LLC reported holding 1,271,948 shares of CAMP (CAMP4 THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$5.6M, representing 3.27% of its reported portfolio and ranking #5 among its reported holdings. HARBOURVEST PARTNERS LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How HARBOURVEST PARTNERS LLC's CAMP position evolved
HARBOURVEST PARTNERS LLC first disclosed a stake in CAMP in Q4 2024 at 1,271,948 shares (US$6.6M). The position peaked in Q4 2025 at 1,271,948 shares, worth US$7.8M. Across 7 filings, HARBOURVEST PARTNERS LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,271,948 shares valued at US$5.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 1.27M | $6.64M | New |
| Q1 2025 | 1.27M | $5.09M | Hold |
| Q2 2025 | 1.27M | $1.84M | Hold |
| Q3 2025 | 1.27M | $3.82M | Hold |
| Q4 2025 | 1.27M | $7.80M | Hold |
| Q1 2026 | 1.27M | $5.61M | Hold |
| Q2 2026 | 1.27M | $5.56M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CAMP and 13F data
CAMP (CAMP4 THERAPEUTICS CORP) is a Health Care company. 37 other funds we track also report a position in CAMP — the largest reported positions include 5AM Venture Management, LLC (US$25.6M), Vivo Capital, LLC (US$18.6M), a16z Capital Management, L.L.C. (US$9.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CAMP
- 5AM Venture Management, LLC 5.87M sh · $25.65M · Q2 2026
- Vivo Capital, LLC 4.25M sh · $18.56M · Q2 2026
- a16z Capital Management, L.L.C. 2.13M sh · $9.29M · Q2 2026
- Trails Edge Capital Partners, LP 1.93M sh · $8.45M · Q2 2026
- Enavate Sciences GP, LLC 1.43M sh · $6.23M · Q2 2026
- Stonepine Capital Management, LLC 1.39M sh · $6.07M · Q2 2026
More on HARBOURVEST PARTNERS LLC
FAQ
How long has HARBOURVEST PARTNERS LLC held CAMP?
HARBOURVEST PARTNERS LLC has disclosed CAMP holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is HARBOURVEST PARTNERS LLC's current position in CAMP?
As of Q2 2026, HARBOURVEST PARTNERS LLC holds 1.27M shares of CAMP (CAMP4 THERAPEUTICS CORP), valued at $5.56M, representing 3.27% of its reported portfolio and ranking #5.
Has HARBOURVEST PARTNERS LLC been buying or selling CAMP?
In the latest 13F filing (Q2 2026), HARBOURVEST PARTNERS LLC held unchanged its position in CAMP. The position peaked in Q4 2025 at 1.27M shares.
Which other funds hold CAMP?
Other major institutional holders of CAMP include 5AM Venture Management, LLC, Vivo Capital, LLC, a16z Capital Management, L.L.C., among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.